Health News

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 1,551,000 shares of its common stock, consisting of stock options to purchase an aggregate of 1,034,000 shares of common stock and restricted stock units (“RSUs”) representing an aggregate of 517,000 shares of common stock, to twelve newly hired employees as an inducement material to their acceptance of em...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the company granted inducement equity awards covering an aggregate of 156,650 shares of its common stock to 19 newly hired employees, consisting of inducement stock options to purchase an aggregate of 89,515 shares of common stock and...

OKLAHOMA CITY--(BUSINESS WIRE)--Chloeta, a premier provider of engineering, scientific and technical solutions to support military, energy, homeland security, emergency preparedness and critical infrastructure requirements, is pleased to announce its achievement of ISO 9001 certification for its Quality Management System (QMS). This milestone reinforces Chloeta’s position as an industry leader in regulatory excellence. This certification reflects Chloeta’s ongoing commitment to maintaining the...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in April of an aggregate of 30,579 restricted stock units (RSUs) of the company’s common stock to 13 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company’s board of directors under the Evolus’ 2023 Inducement Incentive Plan, with a grant d...

MANHASSET, N.Y.--(BUSINESS WIRE)--Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody that depletes B cells and is approved for the treatment of B cell malignancies, benefitted patients with lupus nephritis, a severe complication of lupus that compromises kidney function. The study, which was led by Richard A. Furie, MD, professor in the Feinstein Institutes’ Institute of Molecular Medicine and The Marilyn and Barry Rubenst...

MEXICO CITY & MIAMI & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute acknowledge the conclusion of three years of negotiations on the global pandemic agreement text by congratulating the negotiators—particularly representatives of the Equity and Africa Groups—and recognizing the contributions of key stakeholders, including civil society, who championed equitable access to public health goods. “Even before the COVID-19 pandemic, we beg...

DUBLIN--(BUSINESS WIRE)--The "TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies" report has been added to ResearchAndMarkets.com's offering. The global TCR therapy market is estimated to grow from USD 0.03 billion in the current year to USD 4.13 billion by 2035, at a CAGR of 51% during the forecast period, till 2035. Cancer continues to be one of the key areas of research and drug development within the pharmac...

DUBLIN--(BUSINESS WIRE)--The "Wearable Injectors Market Industry Trends and Global Forecasts to 2035, by Type of Device, Usability, Therapeutic Area and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering. The global wearable injectors market is estimated to grow from USD 4.3 billion in the current year to USD 12.10 billion by 2035, at a CAGR of 9% during the forecast period, till 2035. The last few years have witnessed a rising incidence of chronic illnesses ac...

DUBLIN--(BUSINESS WIRE)--The "Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035, by Type of Therapy Packed, Package Engineering Design, Scale of Operation and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering. The global cell therapy packaging market is estimated to grow from USD 360 million in the current year to USD 1.2 billion by 2035, at a CAGR of 11.8% during the forecast period, till 2035. Over the years, the pharmaceutical indus...

DUBLIN--(BUSINESS WIRE)--The "Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The report delivers an in-depth understanding of Opioid Withdrawal Syndrome, historical and forecasted epidemiology of Opioid Withdrawal Syndrome in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. As the market is derived using the patient-based model, the Opioid Withdrawal Syndrome epidemiology chapter...